Scott Requadt

Founder & CEO

CEO of Prolium Bioscience.

Overview

Companies
1
Roles
Founder & CEO

Companies

1 company
Prolium Bioscience $50M
Private Founder & CEO

Clinical-stage biotech developing PRO-203, a potential best-in-class CD20xCD3 T-cell engager for severe autoimmune diseases including systemic sclerosis and lupus.

Founder data is compiled from company records, public announcements, and verified sources. Roles reflect current or most recent known positions.